Cohort 8

Cardio Intelligent Systems, LLC

WEBSITE

Cardio Intelligent Systems predicts the risk of post-transplant complications, including skin cancer, and improves patient care, resulting in better outcomes and paving the pathway for personalized medicine. In the U.S., 46,632 organ transplants were performed from both living and deceased donors in 2023, representing an 8.7% increase since 2022. Organ transplant patients are, unfortunately, at a higher risk for developing skin cancer compared to the general population. Cardio Intelligent Systems aims to change that statistic with their risk prediction model that would target skin cancers in post-transplant patients.

The Team

Nandini Nair, CEO/CMO

Dongping Du, CTO/CFO

Tara Windsor, Customer Liason Officer (CLO)

Mentors

Mike Ryan, Lead, Staff Liason

Janak Sunuwar

Priya Gill

Netaji Khot

Merrit Brockman

Gilbert Valdez, Specialty

Nick Bergfeld, Executive Coach